Lundbeck Austria GmbH
Lundbeck Austria GmbH, a subsidiary of the global pharmaceutical company Lundbeck, is headquartered in Austria (AT) and operates primarily across Europe. Founded in 1915, Lundbeck has established itself as a leader in the pharmaceutical industry, focusing on the research, development, and marketing of innovative treatments for brain diseases, including depression, schizophrenia, and Alzheimer's disease. With a commitment to improving the lives of patients, Lundbeck Austria offers a range of unique products and services that address unmet medical needs. The company is renowned for its dedication to neuroscience, positioning itself as a key player in the mental health sector. Notable achievements include significant advancements in drug development and a strong market presence, underscoring Lundbeck's role as a trusted partner in mental health care.
DitchCarbon Score
How does Lundbeck Austria GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lundbeck Austria GmbH's score of is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lundbeck Austria GmbH's reported carbon emissions
Lundbeck Austria GmbH, headquartered in Austria, currently does not have publicly available carbon emissions data for the most recent year. As such, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. In the absence of concrete emissions data, it is important to note that Lundbeck is committed to addressing climate change through various initiatives. However, specific reduction targets or commitments, such as those aligned with the Science Based Targets initiative (SBTi), have not been outlined. As the pharmaceutical industry increasingly focuses on sustainability, Lundbeck Austria GmbH's future climate commitments and initiatives will be crucial in contributing to broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lundbeck Austria GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
